Understanding the Benefits and Risks of Pharmaceuticals Workshop Summary (2007) / Chapter Skim
Currently Skimming:
Appendix B Discussion Leader and Speaker Biographies
Appendix B Discussion Leader and Speaker Biographies
Pages 69-86
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 69... ...
Berger has held various positions of responsibility for Phase II to Phase IV clinical trials, outcomes research studies and disease management programs. He is currently Vice President of Outcomes Research and Management (ORM)
|
From page 70... ...
Dr. Fendrick's research focuses on the clinical and economic assessment of medical interventions with special attention to how technological innovation influences clinical practice and impacts health care systems.
|
From page 71... ...
He joined Eli Lilly and Company in 1986, where he has previously served as Director of Anti-Infectives; Group Medical Director, Europe (based in the United Kingdom) ; Executive Director of Health Economics Research and Decision Sciences, Executive Director of Regulatory Affairs responsible for North American Regulatory, Chemistry Manufacturing Control, Planning & Global Operations (safety, labeling, medical information, registration and submissions)
|
From page 72... ...
He is a member of the national Blue Cross and Blue Shield Association Medical Advisory Panel and serves as their Scientific Adviser, and a member of the American Society for Clinical Investigation, the Association of American Physicians, the Institute of Medicine of the National Academy of Sciences, and the National Advisory Council on Aging (National Institutes of Health)
|
From page 73... ...
She currently is a member of the Institute of Medicine Health Sciences Policy Board and Vice Chair of the Institute of Medicine Roundtable on Environmental Health Sciences, Research and Medicine and has served on multiple expert committees for the National Academies of Sciences and the government. She received the Woodrow Wilson Award for Distinguished Government Service from the Johns Hopkins University Alumni Association and the UC Berkeley, School of Public Health Alumna of the Year Award.
|
From page 74... ...
Dr. Graham reached out to risk analysts in Europe, China, Japan and Australia as he helped organize the first World Congress on Risk Analysis (Brussels, 2000)
|
From page 75... ...
Peter Barton Hutt, LL.B., LL.M., is a senior counsel in the Washington, D.C., law firm of Covington & Burling specializing in food and drug law. He graduated from Yale College and Harvard Law School and obtained a Master of Laws degree in Food and Drug Law from NYU Law School.
|
From page 76... ...
Dr. Kweder is board certified in Internal Medicine and continues to practice and teach on a weekly basis at the Uniformed Services University and National Naval Medical Center.
|
From page 77... ...
His research also includes testing new frontiers of genetic risk communication (e.g., how genetic susceptibility affects smoking cessation) -- he currently serves as a consultant to the National Human Genome Research Institute in their efforts to develop effective genetic risk communications.
|
From page 78... ...
Over the last 10 years, he has been developing a regional health information exchange to integrate flows of clinical information between public health providers and other clinicians: making immunization registry data from public health department available to providers, creating regional electronic laboratory reporting, implementing and studying reminders to emergency medicine physicians to screen for selected conditions during outbreaks, and, most recently, working with Dr. Shaun Grannis to create the Public Health Electronic Syndromic Surveillance system for the state of Indiana.
|
From page 79... ...
His career has centered on epidemiologic research on threats to public health and using research findings to support policies that protect population health. His research has addressed indoor and outdoor air pollution, smoking, radiation risks, cancer etiology and outcomes, and sleep.
|
From page 80... ...
Dr. Schulman's research centers on three broad themes: economic evaluation in clinical trials; health services research, including access to care and the impact of managed care on clinical practice; and clinical decision making, especially the assessment of decision making for patients with lifethreatening diseases.
|
From page 81... ...
Since joining Pfizer, Dr. Slavin has been Global Head of Risk Technology within Clinical Technology, directing applied risk research to address the current societal trend towards risk aversion and precaution, by studying risk perception, trust and tolerability of risk.
|
From page 82... ...
and Harvard Medical School. After serving as a medical intern and resident at Massachusetts General Hospital, he spent two years doing research in immunology at the National Institutes of Health and three years at Dartmouth Medical School, where he served as chief medical resident and began his studies of medical decision making.
|
From page 83... ...
The mission of the Center is to improve the health of the public by linking epidemiology, biostatistics, and clinical medicine, bringing epidemiologic research methods to clinical research, clinical insight to epidemiologic research, and an understanding of research methodology to clinical medicine. Since its inception in 1993, the Center has grown to more than 160 faculty members, with an annual budget exceeding $50 million.
|
From page 84... ...
Ubel, M.D., is professor of medicine and professor of psychology at the University of Michigan, a primary care physician at the Ann Arbor Veterans Affairs Medical Center, Associate Director of the Michigan Robert Wood Johnson Clinical Scholars Program, and Director of the Center for Behavioral and Decision Sciences in Medicine at the University of Michigan. His research explores controversial issues about the role of
|
From page 85... ...
. Steven Woloshin, M.D., M.S., is a general internist at the White River Junction Veterans Administration in Vermont and a senior researcher in the VA Outcomes Group, and an associate professor of medicine and community and family medicine at Dartmouth Medical School.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.